Subtopic Deep Dive

Aryl Hydrocarbon Receptor Immunotoxicity
Research Guide

What is Aryl Hydrocarbon Receptor Immunotoxicity?

Aryl Hydrocarbon Receptor (AhR) immunotoxicity refers to the adverse modulation of immune responses by environmental toxins activating the AhR pathway, particularly in T-cell differentiation and regulatory T-cell function.

AhR ligands like dioxins and polycyclic aromatic hydrocarbons (PAHs) suppress monocyte differentiation into macrophages (van Grevenynghe et al., 2003, 159 citations) and influence immune-mediated pathology (Wheeler et al., 2017, 90 citations). Stockinger et al. (2011, 169 citations) detailed external influences on immunity via AhR activation. Over 10 key papers from 2002-2020 explore these mechanisms, with 82-169 citations each.

Curated Papers

Key Challenges

Why It Matters

AhR immunotoxicity links environmental pollutants like PAHs and phthalates to immune dysregulation, contributing to autoimmune diseases and allergies (Stockinger et al., 2011; Bølling et al., 2020, 129 citations). Phthalates enhance adjuvant effects in ovalbumin models, elevating IgE and IL-4 (Guo et al., 2012, 91 citations). Selective AhR modulators offer therapeutic potential for pollution-related immunopathologies (Murray et al., 2009, 96 citations).

Key Research Challenges

Ligand-Specific AhR Modulation

AhR ligands vary in inducing immunotoxicity versus modulation, complicating selective targeting (Murray et al., 2009). Stockinger et al. (2011) highlight differential effects on T-cell subsets. Distinguishing agonism from antagonism remains unresolved.

Environmental Toxin Mixtures

Real-world exposures involve PAH-phthalate mixtures disrupting monocyte and macrophage function (van Grevenynghe et al., 2003; Kuo et al., 2012). Guo et al. (2012) show synergistic pulmonary inflammation. Modeling combined effects challenges in vivo translation.

Translational Immune Pathology

AhR control of immune pathology in mice (Wheeler et al., 2017) poorly predicts human autoimmune risks. Casey et al. (2015, 148 citations) note tumor microenvironment alterations. Bridging rodent-human discrepancies hinders clinical applications.

Essential Papers

External influences on the immune system via activation of the aryl hydrocarbon receptor

Brigitta Stockinger, Keiji Hirota, João H. Duarte et al. · 2011 · Seminars in Immunology · 169 citations

Polycyclic Aromatic Hydrocarbons Inhibit Differentiation of Human Monocytes into Macrophages

Julien van Grevenynghe, Sophie Rion, Eric Le Ferrec et al. · 2003 · The Journal of Immunology · 159 citations

Abstract Polycyclic aromatic hydrocarbons (PAHs) such as benzo(a)pyrene (BP) are ubiquitous environmental carcinogenic contaminants exerting deleterious effects toward cells acting in the immune de...

The effect of environmental chemicals on the tumor microenvironment

Stephanie C. Casey, Monica Vaccari, Fahd Al‐Mulla et al. · 2015 · Carcinogenesis · 148 citations

Potentially carcinogenic compounds may cause cancer through direct DNA damage or through indirect cellular or physiological effects. To study possible carcinogens, the fields of endocrinology, gene...

Phthalate exposure and allergic diseases: Review of epidemiological and experimental evidence

Anette Kocbach Bølling, Kam Sripada, Rune Becher et al. · 2020 · Environment International · 129 citations

COVID-19, an opportunity to reevaluate the correlation between long-term effects of anthropogenic pollutants on viral epidemic/pandemic events and prevalence

Aristidis Tsatsakis, Demetrious Petrakis, Τaxiarchis Κonstantinos Νikolouzakis et al. · 2020 · Food and Chemical Toxicology · 126 citations

Immunomodulatory effects of environmental endocrine disrupting chemicals

Chang‐Hung Kuo, San‐Nan Yang, Po‐Lin Kuo et al. · 2012 · The Kaohsiung Journal of Medical Sciences · 102 citations

Abstract During recent decades more than 100,000 new chemicals have been introduced as common consumer products into our environment. Among these chemicals, endocrine‐disrupting chemicals (EDCs) ar...

Evidence for Ligand-Mediated Selective Modulation of Aryl Hydrocarbon Receptor Activity

Iain A. Murray, José L. Quiles, Colin A. Flaveny et al. · 2009 · Molecular Pharmacology · 96 citations

Reading Guide

Foundational Papers

Start with Stockinger et al. (2011, 169 citations) for AhR-immune overview, van Grevenynghe et al. (2003, 159 citations) for PAH monocyte effects, and Murray et al. (2009, 96 citations) for ligand modulation basics.

Recent Advances

Study Wheeler et al. (2017, 90 citations) on pathology control, Bølling et al. (2020, 129 citations) on phthalate allergies, and Casey et al. (2015, 148 citations) on tumor microenvironments.

Core Methods

Core techniques: Local lymph node assays with B220 markers (Gerberick, 2002), ovalbumin-BALB/c immunization for IgE/IL-4 (Guo et al., 2012), and AhR activity assays for selective ligands (Murray et al., 2009).

How PapersFlow Helps You Research Aryl Hydrocarbon Receptor Immunotoxicity

Discover & Search

Research Agent uses searchPapers and citationGraph on 'aryl hydrocarbon receptor immunotoxicity' to map Stockinger et al. (2011, 169 citations) as central node, linking to van Grevenynghe et al. (2003) and Wheeler et al. (2017). exaSearch uncovers phthalate-AhR interactions from Bølling et al. (2020); findSimilarPapers expands to 50+ related works.

Analyze & Verify

Analysis Agent applies readPaperContent to extract AhR signaling data from Stockinger et al. (2011), then verifyResponse with CoVe chain-of-verification flags inconsistencies across van Grevenynghe et al. (2003) and Murray et al. (2009). runPythonAnalysis processes cytokine levels (IL-4, IFN-γ from Guo et al., 2012) for statistical trends; GRADE grading scores evidence strength for T-cell claims.

Synthesize & Write

Synthesis Agent detects gaps in ligand selectivity between Stockinger et al. (2011) and Murray et al. (2009), flagging contradictions in monocyte effects. Writing Agent uses latexEditText and latexSyncCitations to draft AhR pathway reviews, latexCompile for figures, and exportMermaid for signaling diagrams linking toxins to Tregs.

Use Cases

"Extract cytokine data from phthalate-AhR papers and plot IL-4 vs IFN-γ trends"

Research Agent → searchPapers → Analysis Agent → readPaperContent (Guo et al., 2012) → runPythonAnalysis (pandas plot of IgE/IL-4 data) → matplotlib figure of biomarker shifts.

"Draft LaTeX review on AhR T-cell differentiation with citations"

Research Agent → citationGraph (Stockinger et al., 2011 hub) → Synthesis Agent → gap detection → Writing Agent → latexEditText → latexSyncCitations → latexCompile → PDF with AhR pathway section.

"Find GitHub repos analyzing PAH monocyte inhibition datasets"

Research Agent → searchPapers (van Grevenynghe et al., 2003) → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → R scripts for PAH dose-responses.

Automated Workflows

Deep Research workflow scans 50+ AhR papers via searchPapers → citationGraph, generating structured reports on immunotoxicity trends from Stockinger et al. (2011) to Wheeler et al. (2017). DeepScan applies 7-step CoVe analysis to verify phthalate adjuvant effects (Guo et al., 2012), with GRADE checkpoints. Theorizer builds hypotheses on AhR modulation for allergy prevention from Bølling et al. (2020).

Try Doxa for Aryl Hydrocarbon Receptor Immunotoxicity Research

Frequently Asked Questions

What defines AhR immunotoxicity?

AhR immunotoxicity is the disruption of immune cells like T-cells and monocytes by toxins activating AhR (Stockinger et al., 2011; van Grevenynghe et al., 2003).

What are key methods in AhR immunotoxicity studies?

Methods include ovalbumin immunization models for phthalates (Guo et al., 2012), monocyte differentiation assays for PAHs (van Grevenynghe et al., 2003), and ligand selectivity tests (Murray et al., 2009).

What are the most cited papers?

Top papers: Stockinger et al. (2011, 169 citations) on AhR influences; van Grevenynghe et al. (2003, 159 citations) on PAH monocyte inhibition.

What open problems exist?

Challenges include mixture effects of toxins, human translation from mouse models (Wheeler et al., 2017), and selective AhR modulators for therapy (Murray et al., 2009).